Publications | CDI Pathogenesis and Therapy - Wang Lab at Biomedical Sciences of HCOM

2022

Wang, Shaohua. 2022. “Protection of Cognitive Decline and Alzheimer’s Disease Progression by a Human Origin‐probiotic Biotherapy.”

2021

Wang, Shaohua. 2021. “A Novel Probiotics Therapy for Aging-Related Leaky Gut and Inflammation.”

Wang, Shaohua. 2021. “Metformin Reduces Clostridium Difficile infection.”

Wang, Shaohua. 2021. “Microbiota Induces Aging-Related Leaky Gut and Inflammation by Dampening Mucin Barriers and Butyrate-FFAR2/3 Signaling.”

2020

Wang, Shaohua. 2020. “Metformin Reduces Aging-Related Leaky Gut and Improves Cognitive Function by Beneficially Modulating Gut Microbiome/Goblet Cell/Mucin Axis.”

Wang, Shaohua. 2020. “Gut Mycobiome and Its Interaction With Diet, Gut Bacteria and Alzheimer’s Disease Markers in Subjects With Mild Cognitive Impairment: A Pilot Study.”

Wang, Shaohua. 2020. “Lipoteichoic Acid from the Cell Wall of a Heat Killed Lactobacillus Paracasei D3-5 Ameliorates Aging-Related Leaky Gut, Inflammation and Improves Physical and Cognitive.”

Wang, Shaohua. 2020. “A Human-Origin Probiotic Cocktail Ameliorates Aging-Related Leaky Gut and Inflammation via Modulating the Microbiota/Taurine/Tight Junction Axis.”

2019

Wang, Shaohua. 2019. “A Human‐origin Probiotics Cocktail Exhibit Cardio‐protective Effects Independent of GLP‐1 Receptor Signaling.”

Wang, Shaohua. 2019. “Ketogenic Diet Improves Gut Microbiome and Alzheimer’s Disease Markers.”